CTLA4 and neoplasm: Overall, the high ICOS+ Teff to ICOS+ Treg ratio induced by MVA-BN-HER2 alone or in combination with CTLA-4 blockade likely reflects a more effective immune response and correlated with strong anti-tumor efficacy.